Smoking Cessation Aids and Strategies: Insights from Norway's Population

Nov.07.2022
Smoking Cessation Aids and Strategies: Insights from Norway's Population
Study finds smokers in Norway prefer e-cigarettes and snus as aids to quitting and non-users rarely use other aids.

According to a study titled "Smoking Cessation Aids and Strategies: A Population Survey of Former and Current Smokers in Norway," smokers tend to choose from various smoking cessation aids and strategies during their quitting process.


Smoking rates in Norway have decreased from 30% in 2001 to 12% in 2018. Tobacco consumption in the country is divided into combustible products (cigarettes) and non-combustible products (oral tobacco).


The research team conducted a cross-sectional study in Norway in 2017, 2018, 2019 and 2020. The analyzed sample consisted of adult smokers who were grouped according to the number of times they attempted to quit smoking.


A study has shown that among daily smokers, 56% reported using smoking cessation aids, with electronic cigarettes and nicotine mouth sprays being the most popular types. Interestingly, smokers who use nicotine mouth sprays are less likely to use other nicotine replacement therapies. In fact, using mouth sprays and having a support system through online communities and mobile apps are associated with increased success in quitting smoking, while using NRT is linked to failed attempts to quit. When looking at individual aids and combined use of aids, only nicotine mouth sprays were found to be directly linked to successful smoking cessation.


Researchers also found that smokers who use Snus often do not use other smoking cessation aids. "It was discovered that using Snus is an "independent" smoking cessation aid, with only weak associations with the use of other aids. Further investigation is needed into preferences for smoking cessation aids, especially among smokers who have little or no access to healthcare and/or find traditional cessation aids unappealing.


Statement:


This article is compiled from third-party information sources and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The article's translation is intended solely for industry communication and research.


Due to the limitations of the compiler's abilities, the translated article may not fully convey the same meaning as the original. Therefore, please refer to the original text for accuracy.


2FIRSTS maintains full alignment with the Chinese government regarding any domestic or international issues involving Hong Kong, Macau, Taiwan, and foreign relations.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai
Singapore sentencing: 17,000+ vape pods seized; man convicted of multiple offences
Singapore sentencing: 17,000+ vape pods seized; man convicted of multiple offences
A 28-year-old man in Singapore was sentenced on Jan 22 after admitting to six offences spanning 2021 to 2024, including possessing vapes and vape pods for sale.
Jan.23 by 2FIRSTS.ai
British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco South Africa (BATSA) said it will halt local production of factory-made cigarettes and close its manufacturing plant in Heidelberg, Gauteng by the end of 2026, shifting to an import-led supply model. The company said illicit cigarettes now account for about 75% of South Africa’s market, making local manufacturing “unsustainable” and putting around 230 jobs at risk.
Jan.16
West Virginia Bill Seeks to Replace Per-mL Vape Liquid Tax With 50% Sales-Price Tax
West Virginia Bill Seeks to Replace Per-mL Vape Liquid Tax With 50% Sales-Price Tax
West Virginia proposes tax rate adjustments on e-cigarette devices and e-liquids, with penalties for late reporting. Effective from July 1, 2026.
Feb.02 by 2FIRSTS.ai
Russia’s Rostov Region Eyes Full Vape Sales Ban, Signals Tighter Tobacco Retail Rules
Russia’s Rostov Region Eyes Full Vape Sales Ban, Signals Tighter Tobacco Retail Rules
Russia’s Rostov region is preparing to pursue a region-wide ban on vape sales and is also signaling support for broader regional powers to tighten tobacco retail rules. A regional lawmaker said the initiative aligns with a State Duma bill that would allow regions to impose vape sales bans—an initiative he said has presidential backing.
Jan.28 by 2FIRSTS.ai
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China’s top tobacco regulator has issued a directive aimed at preventing excess capacity and curbing “involution-style” competition in the e-cigarette sector. The notice tightens investment controls, formalizes verified capacity management and requires exporters to submit compliance proof for destination markets, signaling a push toward higher industry concentration and stricter cross-border oversight.
Special Report
Feb.13